Hideyuki Okano
Hideyuki Okano is an expert in Biochemistry at Keio University (Japan). Hideyuki Okano has authored 1,547 publications, the most recent in 2026, and is an investigator in 1 clinical trial. SLR score: 4,995 (community average: 125). How the SLR is computed.
LeadR Profile
Biochemistry
Subspecialties: Neurology - Genetics
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1988 - 2026
Number : 1547
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Mitochonic acid 5 alleviates amyotrophic lateral sclerosis phenotypes via mitochondrial augmentation. PMID 42770300 — sclerosis, genes, biomedical research, phenotype, mitochondria, amyotrophic lateral sclerosis, therapeutics | JCI Insight | 2026 | 0 |
| Contribution of copy number variants to schizophrenia in East Asian populations. PMID 42728386 — genome, schizophrenia | Nat Genet | 2026 | 0 |
| Dynamic interactions with neuroblasts promote oligodendrocyte progenitor migration to injured cortex. PMID 42698966 — oligodendroglia, remyelination, brain, adherens junctions, oligodendrocyte precursor cells | iScience | 2026 | 0 |
| The Sox2 regulatory region 42 produces enhancer RNAs that influence neuronal migration during cortical development. PMID 42699760 — cells, neural stem cells, enhancer elements, genetic, regulatory sequences, nucleic acid | iScience | 2026 | 0 |
| From neural development to regenerative medicine: A research journey in stem cell biology, spinal cord repair, and iPSC-based drug discovery. PMID 42568821 — cells, genes, drug discovery, spinal cord, microscopy, electron, scanning transmission, pharmaceutical preparations, regenerative medicine, translational research, biomedical, spinal cord injuries, stem cells, cell biology, spinal cord regeneration, foundations, research, therapeutics, nervous system, spine | Regen Ther | 2026 | 0 |
Clinical Studies 1
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
LeadR Networks
Main global connection map